1. AF.90 RISK FACTORS FOR LIVER DECOMPENSATION AND HCC IN HCV-CIRRHOTIC PATIENTS AFTER DAAS: A MULTICENTER PROSPECTIVE STUDY. (September 2021) Authors: Guarino, M.; Pontillo, G.; Federico, A.; Marignani, M.; Cannavò, M.; Pignata, L.; Cossiga, V.; Capasso, M.; Dallio, M.; Begini, P.; Benigno, R.; Lombardo, F.; Stroffolini, T.; Morisco, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. Issue 3 (30th July 2012) Authors: Morisco, F.; Castiglione, F.; Rispo, A.; Stroffolini, T.; Sansone, S.; Vitale, R.; Guarino, M.; Biancone, L.; Caruso, A.; D'Inca, R.; Marmo, R.; Orlando, A.; Riegler, G.; Donnarumma, L.; Camera, S.; Zorzi, F.; Renna, S.; Bove, V.; Tontini, G.; Vecchi, M. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 3(2013) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prevalence and risk factors for hepatitis C virus infection in a metropolitan area of Italy. (10th February 2016) Authors: Morisco, F.; Loperto, I.; Stroffolini, T.; Lombardo, F.L.; Cossiga, V.; Guarino, M.; De Feo, A.; Caporaso, N. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗